期刊文献+

碱性成纤维生长因子对颅缝细胞成骨分化的影响

Effects of FGF-2 on osteoblastic differentiation in cranial suture cells
原文传递
导出
摘要 目的 探讨碱性成纤维生长因子(FGF-2)对颅缝细胞成骨方向分化的影响.方法 ①获取新生SD大鼠颅骨矢状缝及冠状缝处颅缝细胞.②添加不同浓度FGF-2,观察颅缝细胞ALP染色、ALP活性及成骨标志物(osteocalcin,OC)表达量,了解不同浓度FGF-2对颅缝细胞向成骨分化的影响.结果①各浓度FGF-2作用于颅缝细胞后,ALP染色、活性均较对照组减弱(P <0.05).其中10ng/ml FGF-2诱导的细胞ALP受到的抑制最弱.②各浓度FGF-2作用于颅缝细胞后,OC表达量均较对照组增加(P <0.05).其中10ng/mlFGF-2诱导的细胞其OC表达量最高.结论 ①FGF-2抑制颅缝细胞早期成骨标志物ALP的表达,而增强晚期成骨标志物OC的表达.②较低浓度的FGF-2(10ng/ml)对ALP抑制作用最弱,对OC促进作用最强,最利于促进颅缝细胞向成骨方向分化. Objective To explore the effects of FGF-2 on cranial suture cells osteoblast differentiation. Methods The cranial suture ceils from sagittalis and coronal sutures of the neonatal SD rat were harvested. The FGF-2 at different density was added into the cells for culture and then the cultured cells were observed by ALP staining, ALP activity, OC expression. Results The positive ceils and activities of ALP in the FGF-2 group were lower than those in the control group ( P 〈 0.05 ) , but the inhibition in 10 ng/ml FGF-2 group was weaker than those in the other FGF-2 groups. OC expressions in the FGF-2 groups were higher than that in the control group ( P 〈 0.05 ) , and the induction in 10 ng/ml FGF-2 group was stronger than those in other FGF-2 groups. Conclusion FGF-2 could inhibit the expression of ALP, the early osteoblastic differentiation marker, but enhance the expression of OC, the later osteoblastic differentiation marker. FGF-2 ( 10 ng/ml) at light con- centration is optimum to osteoblastie differentiation in cranial suture cells.
出处 《中国美容整形外科杂志》 CAS 2013年第12期756-759,共4页 Chinese Journal of Aesthetic and Plastic Surgery
关键词 碱性成纤维生长因子 颅缝细胞 成骨分化 Basic fibroblast growth factor Cranial suture cells Osteogenic differentiation
  • 相关文献

参考文献15

  • 1姜陶然,曹德君.FGFRs突变致颅缝早闭机制研究进展[J].中国美容整形外科杂志,2013,24(4):226-228. 被引量:2
  • 2Crane NJ,Morris MD,Ignelzi MA,et al.Raman imaging demonstrates FGF2-induced craniosynostosis in mouse calvaria[J].J Biomed Opt,2005,10(3):031119.
  • 3陈鹏,张波,张莉,张连阳.成纤维细胞生长因子受体2持续增强对骨髓间充质干细胞软骨成骨的影响[J].中华实验外科杂志,2012,29(12):2541-2544. 被引量:4
  • 4Zheng YH,Su K,Jian YT,et al.Basic fibroblast growth factor enhances osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells in coral scaffold constructs[J].J Tissue Eng Regen Med,2011,5(7):540-550.
  • 5Xiao L,Esliger A,Hurley MM.Nuclear fibroblast growth factor 2(FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro[J].J Bone Miner Res,2013,28(1):35-45.
  • 6Yeh E,Fanganiello RD,Sunaga DY,et al.Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome[J].PLoS One,2013,8(4):e60439.
  • 7Muenke M,Schell U,Hehr A,et al.A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome[J].Nat Genet,1994,8(3):269-274.
  • 8Holmes G,Basilico C.Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome[J].Dev Biol,2012,368(2):283-293.
  • 9Agochukwu NB,Solomon BD,Benson LJ,et al.Talocalcaneal coalition in Muenke syndrome:report of a patient,review of the literature in FGFR-related craniosynostoses,and consideration of mechanism[J].Am J Med Genet A,2013,161(3):453-606.
  • 10Coussens AK,Hughes IP,Wilkinson CR,et al.Identification of genes differentially expressed by prematurely fused human sutures using a novel in vivo-in vitro approach[J].Differentiation,2008,76(5):531-545.

二级参考文献30

  • 1Paravatty RP,Ahsan A, Sebastian BT, et al. Apert syndrome:a case report with discussion of craniofacial features. Quintessence Int, 1999, 30:423-426.
  • 2Ornitz DM, Marie PJ. FGF signaling pathways in endochondral and in- tramembranous bone development and human genetic disease. Genes Dev ,2002,16 : 1446-1465.
  • 3Yu K,Xu J, Liu Z, et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteo- blast function and bone growth. Development ,2003,130:5063-3074.
  • 4Marie PJ. Fibroblast growth factor signaling controlling osteoblast dif- ferentiation. Gene,2003,316 : 23-32.
  • 5Yin L, Du X, Li C, et al. A Pro253Arg mutation in fibroblast growth factor receptor 2 ( Fgfr2 ) causes skeleton malformation mimicking hu- man Apert syndrome by affecting both ehondrogenesis and osteogene- sis. Bone ,2008,42:631-643.
  • 6Wang Y,Xiao R, Yang F, et al. Abnormalities in cartilage and bone development in the Apert syndrome FGFR2( +/$252W) mouse. De- velopment, 2005,132 .. 3537 -3548.
  • 7Chert L, Li D, Li C, et al. A Ser252Trp [ corrected ] substitution in mouse fibroblast growth factor receptor 2 ( Fgfr2 ) results in craniosyn- ostosis. Bone ,2003,33 : 169-178.
  • 8Li CF, Hughes-Fulford M. Fibroblast growth factor-2 is an immediate- early gene induced by mechanical stress in osteogenic ceils. J Bone Miner Res,2006 ,21:946-955.
  • 9Cohen MM Jr, Kreiborg S. Growth pattern in the Apert syndrome. Am J Med Genet, 1993,47:617-623.
  • 10Chaudhary LR, Hofmeister AM, Hruska KA. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone ,2004,34:402-411.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部